SEC Form 3: New insider O'Neil Shaun claimed ownership of 288,954 shares (Amendment)
$PAVM
Medical/Dental Instruments
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/22/2022 |
3. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) 02/24/2022 |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common stock(1) | 288,954(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee stock option (right to buy) | (2) | 07/23/2028 | Common stock | 195,108 | 1.58 | D | |
| Employee stock option (right to buy) | (2) | 03/06/2029 | Common stock | 100,000 | 1 | D | |
| Employee stock option (right to buy) | (2) | 03/31/2031 | Common stock | 75,000 | 4.44 | D | |
| Explanation of Responses: |
| 1. Includes 225,000 shares of restricted stock granted to the reporting person pursuant to the issuer's long term incentive equity plan. |
| 2. All options vest as to 1/12 of the shares on the first calendar quarter end after the grant date (i.e., on 9/30/18, 3/31/19 and 6/30/21 for the options expiring on 7/23/28, 3/6/29 and 3/31/31 respectively) and as to an additional 1/12 of the shares on each successive calendar quarter end thereafter. |
| Remarks: |
| This amendment was filed solely to correct (i) the number of shares of common stock held by the reporting person at the time of his appointment as a Section 16 officer of the issuer, as reflected in Table I and (ii) the expiration date of certain of the employee stock options reflected in Table II. The Form 4 filed by the reporting person 2/24/22 has not been amended to reflect the correction to Table I. |
| /s/ Shaun O'Neil | 05/01/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||